140 related articles for article (PubMed ID: 32362194)
41. Development and Optimization of Proniosomal Formulation of Irbesartan Using a Box-Behnken Design to Enhance Oral Bioavailability: Physicochemical Characterization and
Mujtaba MA; Kaleem M; Chaware R; Ingole A; Asiri YI; Hassan MZ; Sabale V; Sabale P; Anwer MK; Mahmood D; Aldawsari MF
ACS Omega; 2024 Apr; 9(14):16346-16357. PubMed ID: 38617636
[TBL] [Abstract][Full Text] [Related]
42. Development and
Khan MI; Yaqoob S; Madni A; Akhtar MF; Sohail MF; Saleem A; Tahir N; Khan KU; Qureshi OS
Biomed Res Int; 2022; 2022():8170318. PubMed ID: 36483631
[TBL] [Abstract][Full Text] [Related]
43. Development of stable tocopherol succinate-loaded ethosomes to enhance transdermal permeation: In vitro and in vivo characterizations.
Akhtar N; Akhtar N
J Cosmet Dermatol; 2022 Oct; 21(10):4942-4955. PubMed ID: 35274433
[TBL] [Abstract][Full Text] [Related]
44. Formulation, optimization, and in vitro evaluation of nanostructured lipid carriers for topical delivery of Apremilast.
Madan JR; Khobaragade S; Dua K; Awasthi R
Dermatol Ther; 2020 May; 33(3):e13370. PubMed ID: 32250507
[TBL] [Abstract][Full Text] [Related]
45. Nonionic surfactant-based vesicular system for transdermal drug delivery.
Ghanbarzadeh S; Khorrami A; Arami S
Drug Deliv; 2015 Dec; 22(8):1071-1077. PubMed ID: 24400680
[TBL] [Abstract][Full Text] [Related]
46. Transdermal ethosomal gel nanocarriers; a promising strategy for enhancement of anti-hypertensive effect of carvedilol.
Ibrahim TM; Abdallah MH; El-Megrab NA; El-Nahas HM
J Liposome Res; 2019 Sep; 29(3):215-228. PubMed ID: 30272506
[TBL] [Abstract][Full Text] [Related]
47. Development, In-Vitro Characterization and Preclinical Evaluation of Esomeprazole-Encapsulated Proniosomal Formulation for the Enhancement of Anti-Ulcer Activity.
Mohanty D; Zafar A; Jafar M; Upadhyay AK; Haque MA; Gupta JK; Bakshi V; Ghoneim MM; Alshehri S; Jahangir MA; Ansari MJ
Molecules; 2022 Apr; 27(9):. PubMed ID: 35566099
[TBL] [Abstract][Full Text] [Related]
48. Single Intravenous Dose of Novel Flurbiprofen-Loaded Proniosome Formulations Provides Prolonged Systemic Exposure and Anti-inflammatory Effect.
Verma P; Prajapati SK; Yadav R; Senyschyn D; Shea PR; Trevaskis NL
Mol Pharm; 2016 Nov; 13(11):3688-3699. PubMed ID: 27632682
[TBL] [Abstract][Full Text] [Related]
49. Proniosomal gel-derived niosomes: an approach to sustain and improve the ocular delivery of brimonidine tartrate; formulation, in-vitro characterization, and in-vivo pharmacodynamic study.
Emad Eldeeb A; Salah S; Ghorab M
Drug Deliv; 2019 Dec; 26(1):509-521. PubMed ID: 31090464
[TBL] [Abstract][Full Text] [Related]
50. Proniosomes as a drug carrier for transdermal delivery of ketorolac.
Alsarra IA; Bosela AA; Ahmed SM; Mahrous GM
Eur J Pharm Biopharm; 2005 Apr; 59(3):485-90. PubMed ID: 15760729
[TBL] [Abstract][Full Text] [Related]
51. Topical nanostructured lipid carrier gel of quercetin and resveratrol: Formulation, optimization, in vitro and ex vivo study for the treatment of skin cancer.
Imran M; Iqubal MK; Imtiyaz K; Saleem S; Mittal S; Rizvi MMA; Ali J; Baboota S
Int J Pharm; 2020 Sep; 587():119705. PubMed ID: 32738456
[TBL] [Abstract][Full Text] [Related]
52. Optimization of Potential Nanoemulgels for Boosting Transdermal Glimepiride Delivery and Upgrading Its Anti-Diabetic Activity.
Abdallah MH; Abu Lila AS; El-Nahas HM; Ibrahim TM
Gels; 2023 Jun; 9(6):. PubMed ID: 37367164
[TBL] [Abstract][Full Text] [Related]
53. Novel Transethosomal Gel Containing Miconazole Nitrate; Development, Characterization, and Enhanced Antifungal Activity.
Asghar Z; Jamshaid T; Sajid-Ur-Rehman M; Jamshaid U; Gad HA
Pharmaceutics; 2023 Oct; 15(11):. PubMed ID: 38004517
[TBL] [Abstract][Full Text] [Related]
54. Hydrogel Containing Solid Lipid Nanoparticles Loaded with Argan Oil and Simvastatin: Preparation, In Vitro and Ex Vivo Assessment.
Khan MFA; Ur Rehman A; Howari H; Alhodaib A; Ullah F; Mustafa ZU; Elaissari A; Ahmed N
Gels; 2022 Apr; 8(5):. PubMed ID: 35621575
[TBL] [Abstract][Full Text] [Related]
55. Transfersomal lyophilized gel of buspirone HCl: formulation, evaluation and statistical optimization.
Shamma RN; Elsayed I
J Liposome Res; 2013 Sep; 23(3):244-54. PubMed ID: 23713516
[TBL] [Abstract][Full Text] [Related]
56. Development and optimization of boswellic acid-loaded proniosomal gel.
Mehta M; Dureja H; Garg M
Drug Deliv; 2016 Oct; 23(8):3072-3081. PubMed ID: 26953869
[TBL] [Abstract][Full Text] [Related]
57. Quality by design (Qbd) assisted development of phytosomal gel of aloe vera extract for topical delivery.
Jain P; Taleuzzaman M; Kala C; Kumar Gupta D; Ali A; Aslam M
J Liposome Res; 2021 Dec; 31(4):381-388. PubMed ID: 33183121
[TBL] [Abstract][Full Text] [Related]
58. Sorbitan monopalmitate-based proniosomes for transdermal delivery of chlorpheniramine maleate.
Varshosaz J; Pardakhty A; Baharanchi SM
Drug Deliv; 2005; 12(2):75-82. PubMed ID: 15824032
[TBL] [Abstract][Full Text] [Related]
59. Compritol-Based Nanostrucutured Lipid Carriers (NLCs) for Augmentation of Zolmitriptan Bioavailability via the Transdermal Route: In Vitro Optimization, Ex Vivo Permeation, In Vivo Pharmacokinetic Study.
Hassan DH; Shohdy JN; El-Setouhy DA; El-Nabarawi M; Naguib MJ
Pharmaceutics; 2022 Jul; 14(7):. PubMed ID: 35890379
[TBL] [Abstract][Full Text] [Related]
60. Development and optimization of a novel drug free nanolipid vesicular system for treatment of osteoarthritis.
El Afify MS; Zein El Dein EA; Elsadek BEM; Mohamed MA; El-Gizawy SA
Drug Dev Ind Pharm; 2018 May; 44(5):767-777. PubMed ID: 29210312
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
